These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26630617)

  • 1. Immediate Effects of 3% Diquafosol and 0.1% Hyaluronic Acid Ophthalmic Solution on Tear Break-Up Time in Normal Human Eyes.
    Nam KT; Ahn SM; Eom Y; Kim HM; Song JS
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):631-5. PubMed ID: 26630617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normal human eyes.
    Yokoi N; Kato H; Kinoshita S
    Am J Ophthalmol; 2014 Jan; 157(1):85-92.e1. PubMed ID: 24200231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models.
    Choi KE; Song JS; Kang B; Eom Y; Kim HM
    Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
    Park DH; Chung JK; Seo DR; Lee SJ
    Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Tear Meniscus Dynamics Using Anterior Segment Swept-Source Optical Coherence Tomography After Topical Solution Instillation for Dry Eye.
    Akiyama-Fukuda R; Usui T; Yoshida T; Yamagami S
    Cornea; 2016 May; 35(5):654-8. PubMed ID: 26989953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diquafosol Ophthalmic Solution Increases Pre- and Postlens Tear Film During Contact Lens Wear in Rabbit Eyes.
    Nagahara Y; Koh S; Oshita Y; Nagano T; Mano H; Nishida K; Watanabe H
    Eye Contact Lens; 2017 Nov; 43(6):378-382. PubMed ID: 27243352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in tear film lipid layer thickness after instillation of 3% diquafosol ophthalmic solution in healthy human eyes.
    Fukuoka S; Arita R
    Ocul Surf; 2017 Oct; 15(4):730-735. PubMed ID: 28363586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
    Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
    Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diquafosol Tetrasodium Increases the Concentration of Mucin-like Substances in Tears of Healthy Human Subjects.
    Shigeyasu C; Hirano S; Akune Y; Yamada M
    Curr Eye Res; 2015 Sep; 40(9):878-83. PubMed ID: 25310688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular Scattering after Instillation of Diquafosol Ophthalmic Solution.
    Kobashi H; Kamiya K; Igarashi A; Miyake T; Shimizu K
    Optom Vis Sci; 2015 Sep; 92(9):e303-9. PubMed ID: 25551688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery.
    Baek J; Doh SH; Chung SK
    Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prominent Decrease of Tear Meniscus Height With Contact Lens Wear and Efficacy of Eye Drop Instillation.
    Nagahara Y; Koh S; Maeda N; Nishida K; Watanabe H
    Eye Contact Lens; 2015 Sep; 41(5):318-22. PubMed ID: 25839348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diquafosol Delivery from Silicone Hydrogel Contact Lenses: Improved Effect on Tear Secretion.
    Dominguez-Godinez C; Carracedo G; Pintor J
    J Ocul Pharmacol Ther; 2018; 34(1-2):170-176. PubMed ID: 28700254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
    Mun Y; Kwon JW; Oh JY
    BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
    Keating GM
    Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
    Shigeyasu C; Yamada M; Akune Y; Tsubota K
    Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diquafosol three per cent ophthalmic solution on tear film and corneal aberrations after cataract surgery.
    Lee H; Kim SM; Choi S; Seo KY; Kim EK; Kim TI
    Clin Exp Optom; 2017 Nov; 100(6):590-594. PubMed ID: 28222481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    Hori Y; Kageyama T; Sakamoto A; Shiba T; Nakamura M; Maeno T
    J Ocul Pharmacol Ther; 2017; 33(6):493-497. PubMed ID: 28346860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diquafosol ophthalmic solution on the optical quality of the eyes in patients with aqueous-deficient dry eye.
    Koh S; Maeda N; Ikeda C; Oie Y; Soma T; Tsujikawa M; Watanabe H; Nishida K
    Acta Ophthalmol; 2014 Dec; 92(8):e671-5. PubMed ID: 24863298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
    Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
    Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.